摘要
经导管动脉化疗栓塞术(TACE)是肝细胞癌(简称肝癌)最重要的非手术治疗方法。20世纪70年代,我国介入放射学奠基人之一林贵教授在国内率先开展了肝癌选择性血管造影和栓塞治疗研究,为肝癌TACE治疗做出了突出贡献。目前,肝癌TACE治疗正向规范化、精细化和“个体化”综合治疗方向发展。以TACE为基础的综合治疗方案已成为不可手术切除肝癌最常用的治疗模式。本文总结中国肝癌TACE治疗历史,阐述其治疗现状及对未来肝癌TACE治疗的展望,以此铭记林贵教授等介入先驱对肝癌TACE的贡献,做好新时代下肝癌TACE,同质化提高我国肝癌TACE治疗水平。
Transarterial chemoembolization(TACE)has been the most important non-surgical treatment for hepatocellular carcinoma(HCC).In the 1970s,Professor Gui Lin,one of the pioneers of interventional radiology in China,lead the groundbreaking research on selective angiography and embolization of HCC in China,and made outstanding contributions to the TACE treatment of HCC.At present,TACE treatment of HCC is developing towards the standardization,refinement and“individualized”comprehensive treatment.The comprehensive protocol based on TACE has become the most commonly used treatment mode for unresectable HCC.This article summarizes the history of TACE,expounds the current status,and envisions the future of TACE for HCC in China,so as to remember the contribution of Professor Gui Lin and other interventional pioneers,to spread the excellent TACE for HCC in the new era,and to homogeneously improve TACE level as well.
作者
刘嵘
程永德
王小林
王建华
颜志平
LIU Rong;CHENG Yongde;WANG Xiaolin;WANG Jianhua;YAN Zhiping(Department of Interventional Radiology,Affiliated Zhongshan Hospital,Fudan University,Shanghai 200032,China)
出处
《介入放射学杂志》
CSCD
北大核心
2022年第8期743-746,共4页
Journal of Interventional Radiology
关键词
肝细胞癌
经导管动脉化疗栓塞术
林贵
历史
现状
展望
hepatocellular carcinoma
transarterial chemoembolization
Professor Gui Lin
history
status
future
